Top global pharmaceutical venture financing deals 2014

This statistic displays the value of the top 10 venture financing deals worldwide within the pharmaceutical industry in 2014. In that year, Juno Therapeutics, a biotechnology company was given a venture capital deal valued at 134 million U.S. dollars. In the biotechnology industry, many corporate investors are funding innovation and research, however, high regulations on the market has lowered returns and made venture capital funds less prominent in recent years in this market.

Top 10 venture financing deals in worldwide pharmaceutical industry by value in 2014 (in million U.S. dollars)*

Company	Value in million U.S. dollars
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

June 2015

More information

Region

Worldwide

Survey time period

2014

Supplementary notes

* Includes investments in pharmaceutical and biotech companies. Does not include pure-play genomics or medical device companies. Includes Private Investment in Public Equity (PIPE). Deal value represents the total disclosed value. Deal count includes all deals regardless of whether the value was disclosed.

Citation formats